Clinical Trial Update: Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated the efficacy of topically applied cyclosporine A for treating and preventing endothelial graft rejection in corneal graft recipient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Graft Rejection

Drugs mentioned

• Topical cyclosporine A (cyclosporine A)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Endothelial Graft Rejection | Phase 4 | Status: COMPLETED